U.S. Markets closed

Samsung Electronics Co., Ltd. (SSNLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2,100.000.00 (0.00%)
At close: 3:08PM EDT
Full screen
Previous Close2,100.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume8
Avg. Volume3
Market Cap284.96B
BetaN/A
PE Ratio (TTM)13.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Apple Inc.'s Huge Growth Opportunity
    Motley Fool12 hours ago

    Apple Inc.'s Huge Growth Opportunity

    Taking share from its main rival in the premium smartphone market could be a huge opportunity for Apple.

  • Reuters14 hours ago

    Exclusive: Hyundai Motor Group faces government calls to address 'big governance risk'

    South Korea's new antitrust chief said he has been in talks with the autos-to-steel conglomerate Hyundai Motor Group about overhauling its complex ownership structure, which critics say gives too much power to its controlling family at the expense of shareholders. Kim Sang-jo, appointed to head the Korea Fair Trade Commission by President Moon Jae-in, told Reuters that Hyundai's web of cross shareholdings among its group affiliates has resulted in a "big governance risk" for South Korea's second-largest conglomerate, which is run by its 79-year-old chief, Chung Mong-koo. "Many people, including me, are telling Hyundai that they shouldn't waste more time before dissolving cross shareholding," said Kim, who has been nicknamed "chaebol sniper" for his shareholder activist campaigns targeting South Korea's powerful family-run conglomerates.

  • The Wall Street Journal16 hours ago

    [$$] Samsung Broadens Its Drugs Business

    The Samsung conglomerate is furthering its efforts to build a full-fledged prescription-drugs business, signing its first deal to develop novel drugs for hard-to-treat diseases.